In a study published in the Journal of the American Medical Association, researchers from MIT demonstrated that a 3-mm-long microdevice holding up to 16 different drugs and drug combinations can release those drugs when implanted directly in a tumor to then determine the tumor's sensitivity to those therapies. This could help physicians choose the best possible option to treat the cancer. Article (sub. req.)